Shares of Regeneron Pharmaceuticals (REGN) have lost 21.1% year to date against the industry’s growth of 5.2%. The stock has ...

Novo Nordisk leads globally in GLP-1s despite U.S. pressure, with a strong pipeline, cost cuts, and attractive valuation.

Discover why Novo Nordisk A/S’s 2025 restructuring and staff cuts shouldn't deter investors. Click to explore the long-term ...

Private equity company Permira is looking to offload its CDMO Cambrex in a sale that could value the latter company at up to ...

In-vitro toxicology testing market was valued at US$ 26.00 billion in 2024 and is projected to hit the market valuation of US$ 57.55 billion by 2033 at a CAGR of 9.23% during the forecast period ...

Denis Johnson became CEO on Sept. 1 at the Grand Rapids-based contract manufacturer Grand River Aseptic Manufacturing.

The global lentiviral vector CDMO market is set to witness a growth rate of 8% in the next 5 years. Growing demand for gene ...

据路透社援引两位“直接参与讨论”的投资人士称，艾兰得公司已经聘请高盛在中美两地同时接洽战略买家与PE基金，但尚未设定接收非约束性报价的截止日期。据此，外界猜测该计划仍处于早期阶段。

Impurities and instability are challenges for all drugs, but a growing range of technological tools are helping drug developers and manufacturers minimize them.

The Danish pharmaceutical company Novo Nordisk is cutting 9,000 jobs, 4,000 of which will be outside Denmark. The company, one of Bloomington’s major employers, did not comment on whether any jobs at ...

A midstage study of the psychedelic drug LSD showed positive results for easing symptoms in people with generalized anxiety ...

近日，私募股权公司Permira正在考虑以高达40亿美元的价格出售其旗下的合同药物制造公司Cambrex。这一消息来自于《金融时报》的报道，Permira希望借此吸引对Cambrex等制造商日益增长的投资者兴趣。 此次出售的背景是，随着特朗普政府推动将药品生产带回美国，合同药物制造商正在受益。政府多次威胁对进口药品征收高额关税，进一步刺激了市场的关注。Permira在2019年以24亿美元收购了C ...